Top Markets
#1 Islamic Coin Islamic Coin +154.31%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +31.84%
#4 RedStone RedStone +17.28%
#5 edgeX edgeX +16.67%
#6 Starpower Starpower +15.48%
#7 Bio Protocol Bio Protocol +12.37%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.27%
#9 Lighter Lighter +12.26%
#10 Monad Monad +11.38%
Coin of the day
Islamic Coin Islamic Coin
Настройки
Язык
Pусский
Валюта
USD
Тема
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Ранг среди акций #27803
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Цена акции
$0.0492516
Рыночная капитализация
$30.41M
Изменение (1 день)
1.32%
Изменение (1 год)
-91.28%
Страна
CN
Торговля Immunotech Biopharm Ltd (6978)

Категория

Healthcare
Выручка компании Immunotech Biopharm Ltd (6978)
Выручка на Aug 2026 TTM: 0
Согласно последним финансовым отчетам Immunotech Biopharm Ltd, текущая выручка компании (TTM) составляет 0. В 2026 году компания получила выручку 0 равна выручке в 2026 году, которая составила 0. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Immunotech Biopharm Ltd с 2026 по 2026
Выручка на конец каждого года
Год Выручка Изменить
Недостаточно данных для указанных дат.
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH